Xudong Wei
Impact in
- Organic Chemistry top 5%
- Asymmetric Synthesis and Catalysis
- Synthetic Organic Chemistry Methods
- Coordination Chemistry and Organometallics
- Cancer Research top 10%
- NF-κB Signaling Pathways
- MicroRNA in disease regulation
Papers in
- Hematology 44
- Acute Myeloid Leukemia Research 27
- Chronic Myeloid Leukemia Treatments 13
- Hematopoietic Stem Cell Transplantation 11
- Genetics 22
- Chronic Lymphocytic Leukemia Research 12
- Co-authors
- Richard J. K. TaylorJie TianJack J. JiangLei ChengLiang ZhouErwin W. GelfandRuihua FanYongping Song
- Journals
- Blood (6 papers)Tetrahedron Letters (4 papers)Chemical Communications (3 papers)Scientific Reports (2 papers)OncoTargets and Therapy (2 papers)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Xudong Wei
100 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 124
- Organic Chemistry 501
- Cancer Research 181
- Immunology 212
- Immunology and Allergy 57
- Oncology 229
Countries citing papers authored by Xudong Wei
This map shows the geographic impact of Xudong Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xudong Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xudong Wei more than expected).
Fields of papers citing papers by Xudong Wei
This network shows the impact of papers produced by Xudong Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xudong Wei. The network helps show where Xudong Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Xudong Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 3 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 8 | |
| 9 | 2023 | 2 | |
| 10 | 2019 | 6 | |
| 11 | 2017 | 18 | |
| 12 | 2017 | 0 | |
| 13 | 2016 | 1 | |
| 14 | 2016 | 4 | |
| 15 | 2015 | 11 | |
| 16 | 2013 | 1 | |
| 17 | [Clinical significance of dynamic monitoring of thymic recent output function in different stages of treatment in patients with diffuse large B-cell lymphoma]. | 2013 | 2 |
| 18 | 2008 | 99 | |
| 19 | 2004 | 88 | |
| 20 | 2003 | 80 |
About Xudong Wei
Xudong Wei is a scholar working on Hematology, Genetics, Oncology, Organic Chemistry and Emergency Medicine, having authored 120 papers that have together received 1.4k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (27 papers), Chronic Myeloid Leukemia Treatments (13 papers), Chronic Lymphocytic Leukemia Research (12 papers), Hematopoietic Stem Cell Transplantation (11 papers), Retinoids in leukemia and cellular processes (10 papers), Lymphoma Diagnosis and Treatment (8 papers), Cancer Cells and Metastasis (8 papers) and Coordination Chemistry and Organometallics (8 papers). The work is most often cited by research in Organic Chemistry (501 citations), Cancer Research (181 citations), Immunology (212 citations), Immunology and Allergy (57 citations) and Oncology (229 citations). Xudong Wei has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Richard J. K. Taylor, Jie Tian, Jack J. Jiang, Lei Cheng, Liang Zhou, Erwin W. Gelfand, Ruihua Fan, Yongping Song, Gary L. Johnson and Vittorio Farina. Their work appears in journals such as Blood, Tetrahedron Letters, Chemical Communications, Scientific Reports and OncoTargets and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.